Triheptanoin
Contents
Description
Triheptanoin is a medium odd-chain triglyceride that provides an alternative energy source for patients with long-chain fatty acid oxidation disorders. It has been investigated for use in glucose transport disorders as it can provide anaplerotic substrates that bypass glucose metabolism defects. The drug is approved for treatment of molecularly confirmed long-chain fatty acid oxidation disorders.
Indications & Therapeutic Use
glucose transport disorder, long-chain fatty acid oxidation disorders
Global Availability (6 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Triheptanoin — GNH India
4 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Triheptanoin products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | triheptanoin |
| Brands | 1 brand available |
| Active Ingredient | triheptanoin |
| Drug Class | glucose transport disorder |
| Manufacturer | Ultragenyx Pharmaceutical |
| Dosage Forms | oral liquid, 1000mg/mL |
| Medical Code | A16AX12 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 21 days |
| Reg. Status | FDA Approved, EMA Approved |
| Clinical Trial | NCT02214160 |
| Countries | 6 countries |